中华物理医学与康复杂志
中華物理醫學與康複雜誌
중화물리의학여강복잡지
CHINESE JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION
2013年
7期
523-526
,共4页
卞叶萍%童嘉毅%沈祥波%陈龙%杨芳%徐艳娟%闫磊%罗丹%马根山
卞葉萍%童嘉毅%瀋祥波%陳龍%楊芳%徐豔娟%閆磊%囉丹%馬根山
변협평%동가의%침상파%진룡%양방%서염연%염뢰%라단%마근산
心肌梗死%干细胞%超声%微泡%一氧化氮
心肌梗死%榦細胞%超聲%微泡%一氧化氮
심기경사%간세포%초성%미포%일양화담
Myocardial infarction%Stem cells%Ultrasound%Microbubbles agent%Nitric oxide
目的 探讨超声联合一氧化氮(NO)微泡介导间充质干细胞(MSCs)移植对心肌梗死大鼠心功能的影响,并探讨其可能作用机制.方法 选用冠状动脉左前降支结扎法制作心肌梗死模型大鼠28只,采用随机数字表法将其分为对照组(经尾静脉注入磷酸盐缓冲液)、MSCs组(经尾静脉注入MSCs)、普通微泡组(经尾静脉注入普通微泡,同时给予超声干预,然后经尾静脉注入MSCs)及NO微泡组(经尾静脉注入NO微泡,同时给予超声干预,然后经尾静脉注入MSCs),每组7只.各组大鼠分别经治疗4周后行M型心功能彩超检查,计数比较各组大鼠缺血心肌局部平均毛细血管密度,采用蛋白免疫印迹法及实时PCR检测各组大鼠心肌局部血管内皮生长因子(VEGF)表达.结果 治疗4周后发现NO微泡组射血分数[(56.27±3.66)%]较普通微泡组[(51.31±3.22)%]、MSCs组[(45.81±3.37)%]及对照组[(43.66±4.79)%]均显著提高(P<0.05);NO微泡组心肌缺血区域平均毛细血管密度[(45.96±9.01)个/每高倍镜视野]较普通微泡组[(28.07±4.93)个/每高倍镜视野]、MSCs组[(21.41 ±5.27)个/每高倍镜视野]及对照组[(18.04±4.82)个/每高倍镜视野]均显著增加(P<0.05).NO微泡组VEGF相对表达量(0.67 ±0.024)较普通微泡组(0.54 ±0.011)、MSCs组(0.44±0.020)及对照组(0.12±0.009)均显著增强(P<0.05).结论 超声联合NO微泡介导MSCs移植治疗心肌梗死大鼠,能进一步提高模型大鼠心功能,其治疗机制可能与促进局部VEGF表达、加速梗死区域血管生成有关.
目的 探討超聲聯閤一氧化氮(NO)微泡介導間充質榦細胞(MSCs)移植對心肌梗死大鼠心功能的影響,併探討其可能作用機製.方法 選用冠狀動脈左前降支結扎法製作心肌梗死模型大鼠28隻,採用隨機數字錶法將其分為對照組(經尾靜脈註入燐痠鹽緩遲液)、MSCs組(經尾靜脈註入MSCs)、普通微泡組(經尾靜脈註入普通微泡,同時給予超聲榦預,然後經尾靜脈註入MSCs)及NO微泡組(經尾靜脈註入NO微泡,同時給予超聲榦預,然後經尾靜脈註入MSCs),每組7隻.各組大鼠分彆經治療4週後行M型心功能綵超檢查,計數比較各組大鼠缺血心肌跼部平均毛細血管密度,採用蛋白免疫印跡法及實時PCR檢測各組大鼠心肌跼部血管內皮生長因子(VEGF)錶達.結果 治療4週後髮現NO微泡組射血分數[(56.27±3.66)%]較普通微泡組[(51.31±3.22)%]、MSCs組[(45.81±3.37)%]及對照組[(43.66±4.79)%]均顯著提高(P<0.05);NO微泡組心肌缺血區域平均毛細血管密度[(45.96±9.01)箇/每高倍鏡視野]較普通微泡組[(28.07±4.93)箇/每高倍鏡視野]、MSCs組[(21.41 ±5.27)箇/每高倍鏡視野]及對照組[(18.04±4.82)箇/每高倍鏡視野]均顯著增加(P<0.05).NO微泡組VEGF相對錶達量(0.67 ±0.024)較普通微泡組(0.54 ±0.011)、MSCs組(0.44±0.020)及對照組(0.12±0.009)均顯著增彊(P<0.05).結論 超聲聯閤NO微泡介導MSCs移植治療心肌梗死大鼠,能進一步提高模型大鼠心功能,其治療機製可能與促進跼部VEGF錶達、加速梗死區域血管生成有關.
목적 탐토초성연합일양화담(NO)미포개도간충질간세포(MSCs)이식대심기경사대서심공능적영향,병탐토기가능작용궤제.방법 선용관상동맥좌전강지결찰법제작심기경사모형대서28지,채용수궤수자표법장기분위대조조(경미정맥주입린산염완충액)、MSCs조(경미정맥주입MSCs)、보통미포조(경미정맥주입보통미포,동시급여초성간예,연후경미정맥주입MSCs)급NO미포조(경미정맥주입NO미포,동시급여초성간예,연후경미정맥주입MSCs),매조7지.각조대서분별경치료4주후행M형심공능채초검사,계수비교각조대서결혈심기국부평균모세혈관밀도,채용단백면역인적법급실시PCR검측각조대서심기국부혈관내피생장인자(VEGF)표체.결과 치료4주후발현NO미포조사혈분수[(56.27±3.66)%]교보통미포조[(51.31±3.22)%]、MSCs조[(45.81±3.37)%]급대조조[(43.66±4.79)%]균현저제고(P<0.05);NO미포조심기결혈구역평균모세혈관밀도[(45.96±9.01)개/매고배경시야]교보통미포조[(28.07±4.93)개/매고배경시야]、MSCs조[(21.41 ±5.27)개/매고배경시야]급대조조[(18.04±4.82)개/매고배경시야]균현저증가(P<0.05).NO미포조VEGF상대표체량(0.67 ±0.024)교보통미포조(0.54 ±0.011)、MSCs조(0.44±0.020)급대조조(0.12±0.009)균현저증강(P<0.05).결론 초성연합NO미포개도MSCs이식치료심기경사대서,능진일보제고모형대서심공능,기치료궤제가능여촉진국부VEGF표체、가속경사구역혈관생성유관.
Objective To study the effect and possible mechanisms of mesenchymal stem cells (MSCs) transplantion therapy mediated by ultrasound in combination with nitric oxide (NO) microbubbles (MBs)on cardiac function in rats with myocardial infarction (MI).Methods Twenty-eight rats with MI were randomly divided into the following groups by use of random digits table:phosphate buffered saline group (injection of PBS into the tail vein),MSCs group (injection of MSCs into the tail vein),ultrasound + MBs + MSCs group (ultrasound intervention when injection of ordinary MBs into the tail vein followed by injection of MSCs) and ultrasound + NO MBs +MSCs group (ultrasound intervention when injecting NO-MBs into the tail vein followed by injection of MSCs) (n =7,each group).After four weeks,the left ventricular systolic function was evaluated with M-mode ultrasound for each group,capillaries density of myocardial ischemic area was counted in each group,and the expression of vascular endothelial growth factor (VEGF) was detected by Western blot and real time PCR.Results The ejection fraction (EF) of NO-MBs group was significantly higher than the other groups (P <0.05).The number of capillaries in NOMBs group was also much more than that in the other groups (P <0.05).The expression of VEGF in infarcted zone was much higher in the NO-MBs group than that in the other groups (P <0.05).Conclusion Ultrasound and NO MBs-mediated MSCs transplantation therapy could improve the cardiac function of rats after MI,and the possible mechanism was the upregulation of VEGF and angiogenesis.